162 related articles for article (PubMed ID: 37538332)
1. Equivalent efficacy of indoor daylight and lamp-based 5-aminolevulinic acid photodynamic therapy for treatment of actinic keratosis.
Ruiz AJ; LaRochelle EPM; Fahrner MP; Emond JA; Samkoe KS; Pogue BW; Chapman MS
Skin Health Dis; 2023 Aug; 3(4):e226. PubMed ID: 37538332
[TBL] [Abstract][Full Text] [Related]
2. Effective fluence and dose at skin depth of daylight and lamp sources for PpIX-based photodynamic therapy.
Ruiz AJ; LaRochelle EPM; Samkoe KS; Chapman MS; Pogue BW
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103260. PubMed ID: 36627070
[TBL] [Abstract][Full Text] [Related]
3. Daylight photodynamic therapy versus cryosurgery for the treatment and prophylaxis of actinic keratoses of the face - protocol of a multicenter, prospective, randomized, controlled, two-armed study.
Kohl E; Koller M; Zeman F; Szeimies RM; Philipp-Dormston WG; Prager W; Gerber PA; Karrer S
BMC Dermatol; 2017 Oct; 17(1):12. PubMed ID: 29070025
[TBL] [Abstract][Full Text] [Related]
4. The conventional protocol vs. a protocol including illumination with a fabric-based biophotonic device (the Phosistos protocol) in photodynamic therapy for actinic keratosis: a randomized, controlled, noninferiority clinical study.
Mordon S; Vignion-Dewalle AS; Abi-Rached H; Thecua E; Lecomte F; Vicentini C; Deleporte P; Béhal H; Kerob D; Hommel T; Duhamel A; Szeimies RM; Mortier L
Br J Dermatol; 2020 Jan; 182(1):76-84. PubMed ID: 31021404
[TBL] [Abstract][Full Text] [Related]
5. Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study.
Gracia-Cazaña T; Malinis AJG; Almagro-Sánchez M; Linares DP; Gilaberte Y
Photodiagnosis Photodyn Ther; 2019 Sep; 27():34-38. PubMed ID: 31141728
[TBL] [Abstract][Full Text] [Related]
6. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
[TBL] [Abstract][Full Text] [Related]
7. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
[TBL] [Abstract][Full Text] [Related]
8. Use of 5-Aminolevulinic Acid and Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses.
Shive ML; Coakley BJ; Bierman DF; Serowka Lane KL; Wiegell SR; Haedersdal M; Zachary CB
Dermatol Surg; 2019 Apr; 45(4):529-535. PubMed ID: 30807390
[TBL] [Abstract][Full Text] [Related]
9. Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.
O'Gorman SM; Clowry J; Manley M; McCavana J; Gray L; Kavanagh A; Lally A; Collins P
JAMA Dermatol; 2016 Jun; 152(6):638-44. PubMed ID: 26843523
[TBL] [Abstract][Full Text] [Related]
10. Bringing the gentle properties of daylight photodynamic therapy indoors: A systematic review of efficacy and safety.
Heerfordt IM; Philipsen PA; Wulf HC
Photodiagnosis Photodyn Ther; 2022 Sep; 39():102858. PubMed ID: 35421601
[TBL] [Abstract][Full Text] [Related]
11. Home- vs clinic-based daylight photodynamic therapy with 5-aminolevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective study.
Saenz-Guirado S; Ayen-Rodriguez A; Galvez-Moreno M; Velasco-Amador JP; Llamas-Molina JM; Ruiz-Villaverde R; Molina-Leyva A
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104031. PubMed ID: 38438001
[TBL] [Abstract][Full Text] [Related]
12. Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study.
Spelman L; Rubel D; Murrell DF; See JA; Hewitt D; Foley P; Salmon R; Kerob D; Pascual T; Shumack S; Fernandez-Penas P
Australas J Dermatol; 2016 Feb; 57(1):24-8. PubMed ID: 25827200
[TBL] [Abstract][Full Text] [Related]
13. Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
Gutiérrez García-Rodrigo C; Pellegrini C; Piccioni A; Tambone S; Fargnoli MC
Photodiagnosis Photodyn Ther; 2019 Sep; 27():100-104. PubMed ID: 31141730
[TBL] [Abstract][Full Text] [Related]
14. Daylight Photodynamic Therapy for Actinic Keratoses.
Morton CA; Braathen LR
Am J Clin Dermatol; 2018 Oct; 19(5):647-656. PubMed ID: 29752702
[TBL] [Abstract][Full Text] [Related]
15. The impact of occlusive vs non-occlusive application of 5-aminolevulinic acid (BF-200 ALA) on the efficacy and tolerability of photodynamic therapy for actinic keratosis on the scalp and face: A prospective within-patient comparison trial.
Meierhofer C; Silic K; Urban MV; Tanew A; Radakovic S
Photodermatol Photoimmunol Photomed; 2021 Jan; 37(1):56-62. PubMed ID: 32974974
[TBL] [Abstract][Full Text] [Related]
16. Daylight photodynamic therapy: the Southern California experience.
Lane KL; Hovenic W; Ball K; Zachary CB
Lasers Surg Med; 2015 Feb; 47(2):168-72. PubMed ID: 25663047
[TBL] [Abstract][Full Text] [Related]
17. Plum-blossom needle tapping enhances the efficacy of ALA photodynamic therapy for facial actinic keratosis in Chinese population: a randomized, multicenter, prospective, and observer-blind study.
Wang P; Xie F; Zhang L; Zhao S; Zhu L; Shen S; Li D; Chen Z; Xiao R; Lu Y; Lei X; Li Y; Zhang G; Zeng W; Wang X
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103611. PubMed ID: 37211296
[TBL] [Abstract][Full Text] [Related]
18. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia.
See JA; Shumack S; Murrell DF; Rubel DM; Fernández-Peñas P; Salmon R; Hewitt D; Foley P; Spelman L
Australas J Dermatol; 2016 Aug; 57(3):167-74. PubMed ID: 26033230
[TBL] [Abstract][Full Text] [Related]
19. Is a 4 J/cm
Fronville M; Creusot M; Mordon SR
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895925
[No Abstract] [Full Text] [Related]
20. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
